Forman Stephen J. 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Dec 11, 2018
Insider Transaction Report
Form 4
Forman Stephen J.
Director
Transactions
- Purchase
Common Stock
2018-12-07$0.50/sh+100,000$50,000→ 100,000 total(indirect: By Trust) - Purchase
Warrants to Purchase Common Stock
2018-12-07$0.50/sh+100,000$50,000→ 100,000 total(indirect: By Trust)Exercise: $1.00From: 2018-12-07Exp: 2022-12-07→ Common Stock (100,000 underlying)
Holdings
- 22,500
Common Stock
Footnotes (1)
- [F1]The reporting person acquired 100,000 Units, each Unit consisting of one share of Common Stock and a four year warrant at an exercise price of $1.00 per share. The purchase price for a Unit was $0.50 per Unit.